1. 302 CLINICAL CHARACTERISTICS AND PROGNOSIS OF ATYPICAL CHRONIC MYELOID LEUKEMIA – REPORT BY POLISH ADULT LEUKEMIA GROUP. Issue 1 (April 2015) Authors: Drozd-Sokolowska, J.; Madry, K.; Szwedyk, P.; Razny, M.; Bober, G.; Krzemien, H.; Dutka, M.; Piekarska, A.; Stella-Holowiecka, B.; Waszczuk-Gajda, A.; Heleniak, H.; Paszkowska-Kowalewska, M.; Dwilewicz-Trojaczek, J. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P692: IMMUNE FACTORS MAINTAINING TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF IMATINIB. (23rd June 2022) Authors: Kwaśnik, P.; Zaleska, J.; Link-Lenczowska, D.; Zawada, M.; Ochrem, B.; Bober, G.; Wasilewska, E.; Mędraś, E.; Hus, I.; Szarejko, M.; Prejzner, W.; Grzybowska-Izydorczyk, O.; Klonowska-Szymczyk, A.; Sacha, T.; Giannopoulos, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗